NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $6.57 +0.01 (+0.15%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeStance Health Group Stock (NASDAQ:LFST) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get LFST alerts:Sign Up Key Stats Today's Range$6.43▼$6.6050-Day Range$6.13▼$8.1652-Week Range$4.64▼$8.61Volume752,868 shsAverage Volume1.61 million shsMarket Capitalization$2.53 billionP/E RatioN/ADividend YieldN/APrice Target$8.30Consensus RatingModerate Buy Company OverviewLifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Read More… LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 44% of companies evaluated by MarketBeat, and ranked 548th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingLifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 3 research reports in the past 90 days.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.18) to ($0.14) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -25.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -25.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.04% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 8.75%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted8.04% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 8.75%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment1.39 News SentimentLifeStance Health Group has a news sentiment score of 1.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for LifeStance Health Group this week, compared to 3 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $130,128.00 in company stock.Percentage Held by InsidersOnly 6.60% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address LFST Stock News HeadlinesLifeStance Health Group, Inc. Scheduled to Release First Quarter 2025 Earnings on May 7thApril 23, 2025 | nasdaq.comLifeStance Health Group: Solid Execution Drives Growth And Margin ExpansionApril 22, 2025 | seekingalpha.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.April 30, 2025 | Paradigm Press (Ad)LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025April 21, 2025 | globenewswire.comRXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To KnowApril 21, 2025 | msn.com3 Reasons LFST is Risky and 1 Stock to Buy InsteadApril 16, 2025 | msn.comKeybanc Initiates Coverage of LifeStance Health Group (LFST) with Overweight RecommendationApril 9, 2025 | msn.comLifeStance initiated with an Overweight at KeyBancApril 8, 2025 | markets.businessinsider.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.37 on January 1st, 2025. Since then, LFST shares have decreased by 10.9% and is now trading at $6.57. View the best growth stocks for 2025 here. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.05. The business's quarterly revenue was up 18.9% compared to the same quarter last year. Read the conference call transcript. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering (IPO) on Thursday, June 10th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's top institutional shareholders include Brown Advisory Inc. (1.51%), Principal Financial Group Inc. (0.93%), Bank of New York Mellon Corp (0.10%) and SG Americas Securities LLC (0.02%). Insiders that own company stock include Summit Partners Growth Equity, Michael K Lester, Gwen H Booth, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Lisa K Miller, Anisha Patel-Dunn, Ann Varanakis and Paula Cipollone. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings11/07/2024Today4/30/2025Next Earnings (Estimated)5/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees6,640Year FoundedN/APrice Target and Rating Average Stock Price Target$8.30 High Stock Price Target$10.00 Low Stock Price Target$7.00 Potential Upside/Downside+28.5%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-186,260,000.00 Net Margins-7.90% Pretax Margin-7.22% Return on Equity-6.66% Return on Assets-4.51% Debt Debt-to-Equity Ratio0.19 Current Ratio1.32 Quick Ratio1.32 Sales & Book Value Annual Sales$1.25 billion Price / Sales1.99 Cash FlowN/A Price / Cash FlowN/A Book Value$3.77 per share Price / Book1.71Miscellaneous Outstanding Shares384,550,000Free Float357,386,000Market Cap$2.48 billion OptionableOptionable Beta1.30 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:LFST) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.